Diagnostic value of ultrasound examination of skin melanoma for selecting the optimal treatment tactics
DOI:
https://doi.org/10.26641/2307-0404.2025.4.348763Ключові слова:
cutaneous melanoma, invasion depth, skin ultrasound diagnosticsАнотація
Cutaneous melanoma is a malignant tumor characterized by a high risk of both lymphatic and hematogenous metastasis, which represents a negative prognostic factor for affected patients. Although melanoma accounts for only approximately 1% of all skin cancer cases globally, it is responsible for more than 80% of skin cancer-related deaths due to delayed or inaccurate diagnosis. Given the increasing incidence of melanoma, particularly among individuals of Caucasian origin I-II, timely and accurate diagnosis is of critical importance. High-frequency ultrasound (HFUS) is a non-invasive and safe imaging modality that enables the assessment of tumor invasion depth and skin structure prior to surgical intervention. The aim of this study was to evaluate the diagnostic performance of high-frequency ultrasound using a 20-22 MHz probe for the preoperative visualization and assessment of cutaneous melanoma, through comparison with histopathological examination (HPE) data. Specifically, the study analyzed the effectiveness of a linear ultrasound probe with a frequency range of 10-22 MHz on the General Electric LOGIQ E R8 (USA) system, in comparison to the 22 MHz DUB Skinscanner (Germany), for determining tumor invasion depth. Additionally, the study established the statistical correlation between HFUS and histopathological findings, to justify the integration of HFUS into clinical diagnostic algorithms for melanoma as a non-invasive tool for preoperative assessment. A total of 90 patients with dermoscopically suspected melanoma were examined. The results of preoperative HFUS performed with two systems – GE LOGIQ E R8 (USA), using a linear transducer with a central frequency of 10-22 MHz, and the DUB Skinscanner (Germany), with a 22 MHz linear transducer were compared to histopathological data. Based on the results of the statistical analysis, the GE ultrasound system demonstrated a very high level of concordance with histopathological measurements, significantly outperforming the DUB device. These findings support the incorporation of high-frequency ultrasound into the diagnostic algorithm for patients with cutaneous melanoma as a non-invasive and informative method for preoperative evaluation.
Посилання
Hryshchenko RV, Bohomolets OV, Stepanenko VI. [Benign and malignant (melanocytic and non-melanocytic) skin neoplasms: classification, clinical manifestations, diagnosis and treatment tactics]. Ukrainskyi zhurnal dermatolohii, venerolohii, kosmetolohii. 2023;4:20. Ukrainian. doi: https://doi.org/10.30978/UJDVK2023-4-20
Glazer AM, Winkelmann RR, Farberg AS, et al. Digital dermoscopy for monitoring nevus evolution in children: a longitudinal study. JAMA Dermatol. 2020;156(9):976-82. doi: https://doi.org/10.1001/jamadermatol.2020.2430
Arnold M, Holterhues C, Hollestein LM, Coebergh JW, Nijsten T, Pukkala E, et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol. 2014;28(9):1170-8. doi: https://doi.org/10.1111/jdv.12236
Crisan D, Crisan M, Badea R, et al. Ultrasono-graphic assessment of depth infiltration in melanoma and non-melanoma skin cancer. J Ultrasound Med. 2023;42(7):1609-16. doi: https://doi.org/10.1002/jum.16176
Bogomolets O, Rojczyk E, Hryshchenko R, Bogomolets C, Berezkin O. Covid-19, leukemia, and secondary malignancies of the skin – is there a connection: a case report and literature analysis. Front Oncol. 2023;13:1265479. doi: https://doi.org/10.3389/fonc.2023.1265479
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452-8. doi: https://doi.org/10.1038/bmt.2012.244
Kirkwood BR, Sterne JAC. Essential Medical Statistics [Internet]. 2nd Edition. Wiley-Blackwell; 2003 [cited 2025 Apr 12]. 512 p. ISBN: 978–0–86542–871–3. Available from: https://lib.zu.edu.pk/ebookdata/Public%20Health/Essentials%20of%20Medical%20Statistics-by%20Betty%20Kirkwood,%20Jonathan%20Sterne.pdf
Lallas A, Apalla Z, Kyrgidis A, et al. Cutaneous squamous cell carcinoma: a comprehensive review. Cancers (Basel). 2022;14(5):1232. doi: https://doi.org/10.3390/cancers14051232
Wortsman X. Ultrasound in skin cancer: why, how, and when to use it? Cancers (Basel). 2024;16(6):1341. doi: https://doi.org/10.3390/cancers16061341
Swetter SM, Johnson D, Albertini MR, Barker CA, Bateni S, Baumgartner J, et al. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024. J Natl Compr Canc Netw. 2024 Jul 1;22(5):290-8. doi: https://doi.org/10.6004/jnccn.2024.0036
Howell JY, Ramsey ML. Squamous Cell Skin Cancer – StatPearls – NCBI Bookshelf. National Center for Biotechnology Information [Internet]. 2023 [cited 2025 Apr 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441939/
Almuhanna N, Wortsman X, Wohlmuth-Wieser I, Kinoshita-Ise M, Alhusayen R. Overview of ultrasound imaging applications in dermatology. J Cutan Med Surg. 2021;25(5):521-9. doi: https://doi.org/10.1177/1203475421999326
Freschi G, Silvestri M, Russo T, et al. High-frequency ultrasound for preoperative melanoma thickness assessment: correlation with histopathology. Diagnostics (Basel). 2022;12(10):2408. doi: https://doi.org/10.3390/diagnostics12102408
Jiyad Z, Palmer RA, Lear JT. Long-term risk of cutaneous squamous cell and basal cell carcinomas as-sociated with psoralen and ultraviolet A (PUVA) therapy: updated evidence from a cohort study. Br J Dermatol. 2022;186(3):487-94. doi: https://doi.org/10.1111/bjd.20815
Wortsman X. Top applications of dermatologic ultrasonography that can modify management. Ultra-sonography. 2023;42(2):183-202. doi: https://doi.org/10.14366/usg.22130
Sellyn GE, Lopez AA, Ghosh S, Topf MC, Chen H, Tkaczyk E, et al. High-frequency ultrasound accuracy in preoperative cutaneous melanoma assessment: A meta-analysis. J Eur Acad Dermatol Venereol. 2025;39(1):86-96. doi: https://doi.org/10.1111/jdv.20179
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2025 Медичні перспективи

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.



